Matches in DBpedia 2014 for { ?s ?p United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, “[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies.”. }
Showing items 1 to 2 of
2
with 100 items per page.
- United_States_v._Glaxo_Group_Ltd. abstract "United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, “[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies.”".
- United_States_v._Glaxo_Group_Ltd. comment "United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, “[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies.”".